Tag Archive society

Axillary lymph node evaluation performed frequently in ductal carcinoma in situ

Dr. Brilliant no comments

While axillary lymph node evaluation is the standard of care in the surgical management of invasive breast cancer, a benefit has not been demonstrated in ductal carcinoma in situ (DCIS). For women with invasive breast cancer, sentinel lymph node biopsy (SLNB) replaced full axillary lymph node dissection (ALND)…

Most women with early-stage breast cancer avoid extensive lymph node removal

Dr. Brilliant no comments

Until now, it was unclear to what extent surgeons were following the recommendations of a landmark clinical trial published more than four years ago, known as the American College of Surgeons Oncology Group Z0011, or ACOSOG Z-11, trial. Those researchers reported that most early-stage breast cancer patients with tumor in their sentinel lymph node (the first draining node) who undergo lumpectomy do not benefit from surgical removal of the remaining lymph nodes in the underarm area, called completion axillary lymph node dissection (ALND). That study found no difference in cancer recurrence1 and five-year survival2 between patients who underwent ALND and those who did not but were monitored for recurrences…

Women with ovarian cancer gain extra months with addition of drug to standard chemotherapy

Dr. Brilliant no comments

The preliminary findings were reported here at the Society of Gynecologic Oncology’s Annual Meeting on Women’s Cancer. The phase III, randomized, controlled trial included women with platinum-sensitive recurrent ovarian cancer…

How green tea could help improve MRIs

Dr. Brilliant no comments

Sanjay Mathur and colleagues note that recent research has revealed the potential usefulness of nanoparticles — iron oxide in particular — to make biomedical imaging better. But the nanoparticles have their disadvantages. They tend to cluster together easily and need help getting to their destinations in the body. …

Reaching ’80 percent by 2018′ would prevent more than 20,000 colorectal cancer deaths per year

Dr. Brilliant no comments

Colorectal cancer (commonly called colon cancer) is the third leading cause of cancer death in both men and women in the United States, and the second leading cause for both sexes combined. An estimated 132,700 new cases and 49,700 deaths are expected in 2015 in the U.S. Data from the past decade show that both incidence and mortality from colon cancer are decreasing at rate of about 3% per year, largely due to the increased use of screening. Still, fewer than six in ten U.S. …

Chemotherapy after bladder cancer surgery may improve survival

Dr. Brilliant no comments

Clinical trials have established the benefit of giving chemotherapy prior to surgery (neoadjuvant chemotherapy) for patients with bladder cancer. However, clinical trials exploring giving chemotherapy after surgery (adjuvant chemotherapy) have been difficult to interpret and many of the trials closed early due to poor accrual without providing an answer. Lead researcher Matthew Galsky, MD and colleagues used a large database of patients diagnosed with cancer in the United States. Specifically, the study found that patients receiving adjuvant chemotherapy after surgical treatment had improved overall survival when compared to patients that received surgical treatment alone with only post-surgical observation. …

New target for prostate cancer treatment discovered

Dr. Brilliant no comments

Prostate cancer is the second most common cancer in American men, after skin cancer, according to the American Cancer Society (ACS). The ACS projects more than 27,000 deaths from prostate cancer in 2015 and is the second leading cause of cancer death in American men, behind lung cancer. One man in seven will be diagnosed with prostate cancer during his lifetime…

Gene that pushes normal pancreas cells to change shape identified

Dr. Brilliant no comments

Their findings, reported in Nature Communications, suggest that inhibiting the gene, protein kinase D1 (PKD1), and its protein could halt progression and spread of this form of pancreatic cancer, and possibly even reverse the transformation. “As soon as pancreatic cancer develops, it begins to spread, and PKD1 is key to both processes. Given this finding, we are busy developing a PKD1 inhibitor that we can test further,” says the study’s co-lead investigator, Peter Storz, Ph.D., a cancer researcher at Mayo Clinic…

New therapeutic strategy discovered for ovarian cancer

Dr. Brilliant no comments

The findings were published online by the journal Nature Medicine. Ovarian cancer is divided into four different histological subtypes. …

More than 1.5 million cancer deaths averted during 2 decades of dropping mortality — ScienceDaily

Dr. Expert no comments

Each year, the American Cancer Society compiles the most recent data on cancer incidence, mortality, and survival based on incidence data from the National Cancer Institute and the Centers for Disease Control and Prevention, and mortality data from the National Center for Health Statistics. The data are disseminated in two reports: Cancer Statistics 2015, published in CA: A Cancer Journal for Clinicians, and its companion, consumer-friendly publication, Cancer Facts & Figures 2015. The reports also estimate the number of new cancer cases and deaths expected in the United States in the current year. …